Successful treatment of idiopathic orbital inflammation with mycophenolate mofetil.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 16310473)

Published in Am J Ophthalmol on November 01, 2005

Authors

Mark P Hatton1, Peter A D Rubin, C Stephen Foster

Author Affiliations

1: Department of Oculoplastic, Orbit, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.

Articles by these authors

Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med (2010) 4.95

Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol (2011) 3.63

Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol (2003) 3.07

The evolution of endonasal dacryocystorhinostomy. Surv Ophthalmol (2003) 2.46

Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ (2009) 2.23

Plasmapheresis for lupus retinal vasculitis. Arch Ophthalmol (2006) 2.13

The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol (2002) 2.10

Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann Allergy Asthma Immunol (2005) 2.01

Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol (2008) 1.87

Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology (2011) 1.85

Cyclosporine for ocular inflammatory diseases. Ophthalmology (2010) 1.75

Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology (2005) 1.69

Histologic correlation of in vivo optical coherence tomography images of the human retina. Am J Ophthalmol (2006) 1.68

Relapsing polychondritis: a clinical review. Semin Arthritis Rheum (2002) 1.68

Intravitreal bevacizumab for treatment of uveitic macular edema. Ophthalmology (2007) 1.66

Nonsteroidal anti-inflammatory therapy and recurrent acute anterior uveitis. Ocul Immunol Inflamm (2010) 1.62

Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol (2010) 1.61

Methotrexate for ocular inflammatory diseases. Ophthalmology (2009) 1.58

Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol (2008) 1.56

Ocular pemphigus. J Am Acad Dermatol (2005) 1.56

Age- and fatigue-related markers of human faces: an eye-tracking study. Ophthalmology (2008) 1.51

Azathioprine for ocular inflammatory diseases. Am J Ophthalmol (2009) 1.44

Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol (2009) 1.41

Orbital decompression as an alternative management strategy for patients with benign tumors located at the orbital apex. Ophthalmology (2006) 1.39

Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology (2007) 1.36

Etiology and management of idiopathic orbital inflammation. Am J Ophthalmol (2004) 1.33

Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series. Ophthalmology (2005) 1.33

Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin (2006) 1.25

Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol (2008) 1.23

Isolation and characterization of cultured human conjunctival goblet cells. Invest Ophthalmol Vis Sci (2003) 1.23

Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment. Prog Retin Eye Res (2004) 1.20

Multifocal choroiditis and panuveitis: immunomodulatory therapy. Ophthalmology (2002) 1.20

Primary intraocular lymphoma: A review. Semin Ophthalmol (2006) 1.19

Acute posterior multifocal placoid pigment epitheliopathy: outcome and visual prognosis. Retina (2009) 1.19

Bilateral cavernous sinus thromboses and intraorbital abscesses secondary to Streptococcus milleri. Ophthalmology (2003) 1.18

360 degrees iris-ciliary body B-cell lymphoma masquerading as post-cataract uveitis. Semin Ophthalmol (2004) 1.18

High-dose methotrexate for intraocular lymphoma. Clin Cancer Res (2003) 1.15

The clinicopathological spectrum of benign peripunctal tumours. Graefes Arch Clin Exp Ophthalmol (2004) 1.15

Orbital complications of hydrogel scleral buckles. Ophthal Plast Reconstr Surg (2006) 1.15

Cyclophosphamide for ocular inflammatory diseases. Ophthalmology (2009) 1.14

Role of collagen-binding heat shock protein 47 and transforming growth factor-beta1 in conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci (2003) 1.14

Glaucoma and uveitis. Surv Ophthalmol (2012) 1.13

Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol (2007) 1.12

Intravitreal clindamycin for toxoplasmic retinochoroiditis. Retina (2007) 1.11

Idiopathic orbital inflammation: ocular mechanisms and clinicopathology. Ophthalmol Clin North Am (2002) 1.11

Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES): clinical manifestation and treatment. Int Ophthalmol Clin (2008) 1.09

Anterior segment optical coherence tomography. Semin Ophthalmol (2010) 1.09

Biologic response modifier therapy for psoriatic ocular inflammatory disease. Ocul Immunol Inflamm (2008) 1.09

When is enophthalmos "significant"? Ophthal Plast Reconstr Surg (2006) 1.09

Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci (2003) 1.08

Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy. Ophthalmology (2005) 1.08

Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders. Ophthalmology (2003) 1.07

Scleritis therapy. Ophthalmology (2011) 1.07

Comment on "versatile use of extended transconjunctival approach for orbital reconstruction". Ann Plast Surg (2009) 1.07

Limbal stem cell transplantation in chronic inflammatory eye disease. Ophthalmology (2002) 1.07

Wooden intraorbital foreign body injuries: clinical characteristics and outcomes of 23 patients. Ophthal Plast Reconstr Surg (2010) 1.07

Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. Ophthalmology (2006) 1.07

Clinical review: treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm (2009) 1.06

Bilateral uveitis associated with fluoroquinolone therapy. Cutan Ocul Toxicol (2011) 1.05

Vogt-Koyanagi-Harada syndrome associated with bilateral serous macular detachments responsive to immunomodulatory therapy. Ophthalmic Surg Lasers Imaging (2009) 1.05

Sterile corneal melting and necrotizing scleritis after cataract surgery in patients with rheumatoid arthritis and collagen vascular disease. Semin Ophthalmol (2003) 1.04

The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol (2008) 1.04

Risk of hypotony in noninfectious uveitis. Ophthalmology (2012) 1.03

Activation of mitogen-activated protein kinase by cholinergic agonists and EGF in human compared with rat cultured conjunctival goblet cells. Invest Ophthalmol Vis Sci (2003) 1.03

The spectrum of fundus autofluorescence findings in birdshot chorioretinopathy. J Ophthalmol (2010) 1.02

Risk of choroidal neovascularization among the uveitides. Am J Ophthalmol (2013) 1.02

Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm (2004) 1.02

Subconjunctival bevacizumab for corneal neovascularization. Cornea (2008) 1.02

Chronic lymphocytic leukemia of the orbit. Arch Ophthalmol (2002) 1.02

Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol (2007) 1.01

Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis. Ophthalmology (2008) 1.01

The cell-layer- and cell-type-specific distribution of GalNAc-transferases in the ocular surface epithelia is altered during keratinization. Invest Ophthalmol Vis Sci (2003) 1.01

Ocular manifestations and concepts of systemic vasculitides. Surv Ophthalmol (2004) 1.01

Infliximab for the treatment of refractory scleritis. Br J Ophthalmol (2009) 1.01

Pneumocele--a rare cause of air in the orbit. Am J Ophthalmol (2004) 1.01

Visual outcome in herpes simplex virus and varicella zoster virus uveitis: a clinical evaluation and comparison. Ophthalmology (2002) 1.00

Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome. Semin Ophthalmol (2006) 1.00

Hypopyon in patients with uveitis. Ophthalmology (2009) 0.99

Upper and lower eyelid retraction. Int Ophthalmol Clin (2002) 0.99

Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts eye & ear experience and review of previous studies. Ocul Immunol Inflamm (2004) 0.99

Scleral necrosis in a patient with congenital erythropoietic porphyria. Cornea (2011) 0.98

Medial rectus muscle injuries associated with functional endoscopic sinus surgery: characterization and management. Ophthal Plast Reconstr Surg (2003) 0.98

Biological response modifier therapy for refractory childhood uveitis. Br J Ophthalmol (2007) 0.97

Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology (2012) 0.97

Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome. Ophthalmology (2003) 0.96

Chronic postoperative endophthalmitis due to pseudomonas oryzihabitans. Am J Ophthalmol (2002) 0.96

Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment. Semin Ophthalmol (2009) 0.96

Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner choroidopathy. Ocul Immunol Inflamm (2011) 0.96

Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease. Surv Ophthalmol (2011) 0.96

Retained transorbital foreign body with intracranial extension after pipe bomb explosion. Surg Neurol Int (2010) 0.96

Bilateral multifocal hemangiomas of the orbit in the blue rubber bleb nevus syndrome. Ophthalmology (2002) 0.96

Treatment of ocular inflammatory disorders with daclizumab. Ophthalmology (2003) 0.96

Ocular disease in patients with ANCA-positive vasculitis. J Ocul Biol Dis Infor (2009) 0.95

Combined pars plana vitrectomy and phacoemulsification to restore visual acuity in patients with chronic uveitis. J Cataract Refract Surg (2005) 0.94

Infraorbital nerve surgical decompression for chronic infraorbital nerve hyperesthesia. Ophthal Plast Reconstr Surg (2007) 0.94

Discoid lupus erythematosus masquerading as chronic blepharoconjunctivitis. Ophthalmology (2005) 0.93

A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis. J Ocul Pharmacol Ther (2013) 0.93

Multifocal nodular episcleritis and scleritis with undiagnosed Hodgkin's lymphoma. Ophthalmology (2003) 0.93

Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch Ophthalmol (2002) 0.93